ECM
BIO icon

Element Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Element Capital Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,158
Closed -$415K – 32
2023
Q3 		$415K Sell
1,158
-1,613
-58% -$622K 0.04% 215
2023
Q2 		$1.05M Buy
2,771
+151
+6% +$61.4K 0.07% 204
2023
Q1 		$1.26M Buy
+2,620
New +$1.23M 0.09% 145
2022
Q4 		– Sell
-494
Closed -$206K – 46
2022
Q3 		$206K Hold
494
– – 0.1% 133
2022
Q2 		$245K Buy
+494
New +$257K 0.12% 129

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return